癌症患者的电解质异常 在癌症患者中
Arash Rashidi1, Nada Youssef2, Biruh Workeneh2
1Division of Nephrology and Hypertension, Department of Medicine, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
American journal of nephrology
|February 25, 2025
概括
电解质失衡在癌症患者中很常见,会影响治疗和生活质量. 本综述详细介绍了癌症特异性电解质干扰及其管理.
科学领域:
- 在瘤学瘤学.
- 腎臟病學 (nephrology) 是一種醫學專業.
- 内部医学 内部医学
背景情况:
- 电解质障碍在癌症患者中很普遍,影响治疗结果和生活质量.
- 与一般人群相比,这些疾病在癌症治疗中存在独特的挑战,因为它们具有特定的病因和复杂性.
研究的目的:
- 审查癌症患者的关键电解质失衡,包括,,,,和障碍.
- 突出癌症特异性电解质干扰的临床表现和管理策略.
- 强调定期电解质监测和瘤学及时干预的重要性.
主要方法:
- 在癌症患者中对电解质障碍的文献综述.
- 分析与各种癌症治疗相关的电解质失调,包括手术,放射,细胞,检查点抑制剂和细胞毒性化疗治疗.
主要成果:
- 癌症治疗可以导致特定的电解质失衡模式.
- 讨论的常见电解质障碍包括低血,高血,低血,高血以及,和的异常.
结论:
- 了解与癌症相关的电解质疾病的发病因子对于有效的管理至关重要.
- 及时干预和定期监测对于优化护理和改善患有电解质障碍的癌症患者的治疗结果至关重要.
相关概念视频
Roles of Electrolytes: Sodium and Potassium
236
Sodium plays a crucial role in maintaining fluid and electrolyte balance and overall bodily homeostasis. Sodium balance is primarily regulated by kidney function, which adjusts sodium elimination to match dietary intake and maintain proper electrolyte levels. Sodium is the most abundant cation in the extracellular fluid (ECF) and is found in salts such as sodium chloride (NaCl) and sodium bicarbonate (NaHCO3). Although cellular plasma membranes are relatively impermeable to sodium, its role in...
236
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Electron Transport Chain: Complex I and II
10.1K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
10.1K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Transcellular Transport of Solutes
3.4K
Transcellular transport of solutes is the movement of substances like monosaccharides and amino acids through polarized cells. This transport mechanism is primarily seen in epithelial and endothelial cells aided by membrane transport proteins such as channels and transporters. The tight junctions between these cells confine the membrane proteins to the two sides of the cell. The epithelial cells have distinct apical and basolateral domains. In contrast, the endothelial cells show the luminal...
3.4K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K


